Go Back
Agnès Mihajlovski
CY Cergy Paris University
Contact
About
First Name
Agnès
Last Name
Mihajlovski
University
CY Cergy Paris University
Current position
Assistant Professor / Lecturer
Email
agnes.mihajlovski@cyu.fr
Researcher Identification
Google Scholar
Google Scholar
https://scholar.google.fr/scholar?as_ylo=2023&q=agn%C3%A8s+mihajlovski&hl=fr&as_sdt=0,5
Keywords
Molecular microbiology; microbial ecology; phage engineering; phage therapy; antimicrobial resistance; biofilms; combination therapy; bacteriophages; phage-derived enzymes; translational research
Health related-scientific domains
Applied Medical Technologies, Diagnostics, Therapies
Life Sciences related to Health
Research expertise/competencies
Experienced researcher in molecular microbiology, I work on the engineering and application of bacteriophages to address challenges related to antimicrobial resistance (AMR) and biofilm-associated infections. My work combines phage therapy, phage-derived enzymes, and biomaterials science to develop advanced solutions for infection control in medical devices and other clinical applications. By adopting a translational research approach, I try to bridge fundamental discoveries with tangible medical and industrial innovations.
Faculty / Institute / Department
U.F.R. Sciences et Techniques - CY Université Cergy-Pontoise
Research center/group
ERRMECe lab
Research center/group website
Available major infrastructure
Microscopy: Live imaging, confocal microscopy, SEM, AFM
Molecular Microbiology: Real-time qPCR, PCR, transilluminator, NanoDrop, electroporators
Biosafety Labs : fully equiped for biofilm studies
Biochemistry: Equipment for protein production, purification, and characterization
Infrastructure website
Collaboration-based research services
Isolation and comprehensive characterization of novel bacteriophages, Phage engineering; optimization of combination therapies involving phages; genomic analysis of bacteriophages and resistant pathogens.
Contractual research services
Isolation and comprehensive characterization of novel bacteriophages, Phage engineering; optimization of combination therapies involving phages; genomic analysis of bacteriophages and resistant pathogens.
Topics for collaboration
Isolation and comprehensive characterization of novel bacteriophages.
Development of engineered bacteriophages for antimicrobial resistance applications.
Exploration of phage-derived enzymes for biofilm disruption and pathogen control.
Creation of antimicrobial coatings for infection-resistant medical devices.
Optimization of combination therapies involving phages or phage-derived enzymes.
Preclinical testing of phage-based therapies in infection models.
Integration of phages into biomaterials for clinical and industrial use.
